50 employees
Immune System Therapeutics develops monoclonal antibody technologies for the treatment of blood cancers and other blood disorders.
2001
$700K
from 1 investors over 1 rounds
Immune System Therapeutics Ltd raised $700K on March 10, 2005
Investors: Symbion Pharmacy Services